NASDAQ OMX

Aryaka's 2017 State of the WAN Report Reveals Almost 50% of Enterprise Traffic is Composed of Cloud and SaaS Traffic

Dela

The report covers application response times and inconsistencies over the public Internet between various regions and bandwidth consumption changes year-over-year across verticals

MILPITAS, Calif., May 11, 2017 (GLOBE NEWSWIRE) -- Aryaka®, the leading global SD-WAN provider, today released its third edition of the State of the WAN Report. Leveraging its unique position as a leader in global connectivity, Aryaka aggregated and analyzed enterprise WAN traffic over the past four years to identify trends and challenges in application performance, WAN reliability, and bandwidth access between specific geographies and in different industries.

This year's report gives insights into current trends regarding WAN traffic and application performance to help IT managers and decision makers provide support for their global enterprise networks in the coming years. With data aggregated from over 5000 sites in 63 countries, this report gives a detailed look into the current state of WAN infrastructure and its impact on global business.

"Understanding the state of the WAN - and the impacts that global network traffic has on business strategy - gives IT leaders the ability to partner with their C-suite to enhance business execution," said Shawn Farshchi, Aryaka's President and CEO. "With nearly 50% of all global enterprise traffic now comprising cloud and SaaS, and legacy technologies, like MPLS, failing to address this trend, the ability to address the needs of the business translates into better business execution and competitive advantage."

This is the third edition of the State of the WAN report published by Aryaka. Previous versions of the report have examined factors influencing enterprise WAN performance, including packet loss at the last-mile, application use, and bandwidth consumption. The current edition of the report also analyzes typical application performance time over the public Internet, along with the extent of the network inconsistencies that affect mission-critical applications over this medium.

Key insights from the study include:

  • Global enterprise WAN traffic is growing about 200% annually. 

  • Among all regions, Asia-Pacific saw the biggest spike in WAN traffic (248%) in 2016, suggesting that companies in this region are rapidly adopting cloud technology and transforming their businesses to compete in a digital world. In addition, the use of 100 Mbps links in China rose dramatically in 2016, from 6% of links the previous year to 25% of links this year. This shows the power and growth of the Chinese economy overall as it closes the gap with Western countries in terms of demand for high-speed connectivity. 

  • By industry, the Manufacturing vertical saw a massive 440% increase in WAN traffic last year. Other verticals at the cutting edge of innovation include the Software and Internet sector, which grew network traffic by 526%, as well as the Real Estate, Energy and Utilities, and Travel industries, whose WAN traffic grew by around 200%.

  • HTTP and HTTPS together now make up close to 50% of all WAN traffic. Previously, the majority of WAN traffic was of the client-server variety, with traffic moving to and from the data center. But the increased adoption of cloud services has greatly driven up the amount of Internet traffic within the enterprise. 

  • Internet bandwidths and quality are increasing at the WAN edge and over short distances. However, the hand-off between ISPs over the Internet or IP-VPN is getting worse, affecting the performance of business-critical applications, such as ERP or hosted voice and video. For data and applications being transferred over long distances, the middle mile remains unreliable and is riddled with latency, packet loss, and jitter - suggesting that the Internet is not the new enterprise network, as others have suggested.

The full report expands on this data and includes for the first time an in-depth breakdown of variation in application response time globally when the public Internet is used as the middle mile. 

Download the 2017 State of the WAN report now.

For more information about Aryaka's next-generation global SD-WAN, visit www.aryaka.com.

About Aryaka
Aryaka is transforming how global enterprises connect sites and users worldwide, and use mission-critical applications to support modern business execution demands. Aryaka's Global SD-WAN combines a purpose-built private network, SD-WAN, optimization and acceleration techniques, connectivity to cloud platforms, and network visibility in a single solution that is delivered as a service.

To learn more, visit www.aryaka.com. Follow us on TwitterFacebookYouTube and LinkedIn.

Aryaka Media Contact
Shehzad Karkhanawala
Public Relations Manager
Aryaka
408-273-8420
pr@aryaka.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Aryaka via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Oxford Immunotec to Present at the 29th Annual Piper Jaffray Healthcare Conference21.11.2017 15:15Pressmeddelande

OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced that Peter Wrighton-Smith, Chief Executive Officer, will present at the 29th Annual Piper Jaffray Healthcare Conference on Tuesday, November 28th, at 12:00 p.m. EST. The conference will be held at the Lotte New York Palace. A live webcast of the presentation will be available online from the investor relations page of the Company's corporate website at www.oxfordimmunotec.com. A webcast replay will be available approximately two hours after the live presentation and will be archived on the website for approximately 90 days. About Oxford Immunotec Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and comme

OmniComm Systems Signs Letter of Intent to Acquire Certain Assets of Algorithm and its Subsidiary Algorics21.11.2017 14:00Pressmeddelande

Acquisition Will Expand OmniComm's Product Line With Data Analytics and Risk-Based Monitoring Solutions FORT LAUDERDALE, Fla., Nov. 21, 2017 (GLOBE NEWSWIRE) -- OmniComm Systems, Inc. (OTCQX:OMCM), a leading global provider of clinical data management technology, and  Algorithm, Inc. and its subsidiaries Algorics Ltd. and Algorithm Informatics Pvt. Ltd. (collectively, "Algorics"), have signed a letter of intent ("LOI"), under which OmniComm will acquire certain assets and assume certain liabilities of Algorics, a provider of clinical analytics solutions and software. By combining forces, the companies expect increased operating efficiency, strengthened traction in the maturing risk-based approach solution area, new marketing opportunities and an expanded portfolio of electronic data capture (EDC) solutions for the global clinical trials industry. The transaction would also provide OmniComm with an office in India, a country of growing importance in t

CrownBio's Translatable FATZO Model Utilized in Eli Lilly's Preclinical Type 2 Diabetes Research Programs21.11.2017 14:00Pressmeddelande

SANTA CLARA, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces the publication of two new papers. These joint publications illustrate the utility of Crown Bioscience's proprietary FATZO model as a model for obesity and type 2 diabetes in preclinical studies. The research conducted by Crown Bioscience, Eli Lilly and Company and Ball State University was published in two PLOS ONE papers: Peterson et al. Glucose dysregulation and response to common anti-diabetic agents in the FATZO/Pco model PLOS One 2017;12 (6):e0179856, https://doi.org/10.1371/journal.pone.0179856  Droz et al. Correlation of disease severity with body weight and high fat diet in the FATZO/Pco model PLOS One 2017;1

Port Moresby Stock Exchange (POMSoX) Launches New Nasdaq Trading System21.11.2017 11:31Pressmeddelande

NEW YORK and PORT MORESBY, Papua New Guinea, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Nasdaq Inc. (NASDAQ:NDAQ) and the Port Moresby Stock Exchange (POMSoX) have announced that POMSoX has gone live with the widely deployed Nasdaq Matching Engine that operates on the Nasdaq Financial Framework platform. The launch of the new trading platform is a result of an upgrade from previous Nasdaq trading technology. The new trading engine will handle the trading of equities in the Papua New Guinea market. POMSoX has been a customer of Nasdaq since 1999.  "The Nasdaq trading platform will allow significant innovation in terms of market design and market offerings," said Johnson Kalo, a POMSoX board member said. "We believe the platform will provide strong support for future growth in the PNG market and provide new business opportunities in areas such as market data distribution." "We are pleased to continue to support POMSoX, a longstanding Nasdaq customer," said Robert Frojd, Regional Man

CloudCraze Joins the Pledge 1% Movement, Makes Commitment to Philanthropic Leadership21.11.2017 08:00Pressmeddelande

CloudCraze will leverage profit and employee time to improve communities around the world LONDON, Nov. 21, 2017 (GLOBE NEWSWIRE) -- CloudCraze, the enterprise B2B commerce platform built natively on Salesforce, has joined Pledge 1%, a corporate philanthropy movement dedicated to making the community a key stakeholder in every business. Spearheaded by Atlassian, Rally, Salesforce and Tides, Pledge 1% empowers companies to donate 1% of product, 1% of equity, 1% of profit or 1% of employee time to improve communities around the world. CloudCraze is joining an impressive network of entrepreneurs and companies across the globe that have committed to philanthropic efforts through the Pledge 1% movement. By pledging 1% of its profit and employee time, CloudCraze is demonstrating a commitment to philanthropic leadership. "We are incredibly excited that CloudCraze has taken the pledge," said Amy Lesnick, chief executive of Pledge 1%. "CloudCraze can play a pivotal role i

HemChecks avläsare kalibrerad med toppresultat - Regulatorisk20.11.2017 16:18Pressmeddelande

HemChecks avläsare kalibrerad med toppresultat Det medicintekniska bolaget HemCheck, som utvecklar ett patientnära test för detektion av hemolys, kan idag meddela att den digitala avläsare som utgör en del av bolagets produktkoncept Helge, kalibrerats med mycket gott resultat. Detta skedde genom studier i egen regi. Avläsaren kan nu färdigställas och produktkonceptet kommer därmed ett steg närmare CE-märkning. Som ett led i att färdigställa bolagets produktkoncept Helge har HemCheck under hösten utfört studier i egen regi med hjälp av blod från frivilliga bloddonatorer. Syftet var att kalibrera avläsaren och på så sätt möjliggöra en patientnära avläsning av hemolys, det vill säga redan på ett tidigt stadium avgöra om blodprovet är användbart och kan ska skickas till analys.   -Enkelt utryckt har vi lärt avläsaren att mäta hemolys på våra engångstester. Det är en viktig milstolpe och en stor framgång. Nu känner vi oss redo

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum